Survival outcomes among patients with multiple myeloma in the era of novel agents: exploratory assessment using an electronic medical record database in Japan.
Despite recent advances in the range of therapies available for the treatment of multiple myeloma (MM), there are limited data surrounding survival outcomes and baseline characteristics influencing survival in general clinical practice in Japan. The aim of this study was to use electronic medical re...
Main Authors: | Shuji Uno, Shuichi Midorikawa, Kei Inoue, Daisuke Ichikawa, Tomoki Ito, Junya Kuroda, Kenshi Suzuki |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0285947 |
Similar Items
-
Survival outcomes among patients with multiple myeloma in the era of novel agents: exploratory assessment using an electronic medical record database in Japan
by: Shuji Uno, et al.
Published: (2023-01-01) -
Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database.
by: Hiroshi Handa, et al.
Published: (2023-01-01) -
Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database
by: Hiroshi Handa, et al.
Published: (2023-01-01) -
Impact of CRAB symptoms in survival of patients with symptomatic myeloma in novel agent era
by: Aya Nakaya, et al.
Published: (2017-02-01) -
Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum
by: Aya Nakaya, et al.
Published: (2021-11-01)